Antibiotic use in Australian and Swedish primary care: a cross-country comparison

References

• Founou RC, Founou LL, Essack SY. Clinical and economic impact of antibiotic resistance in developing countries: a systematic review and Meta-analysis. PLoS One. 2017;12(12):e0189621.
   PubMed Web of Science ®Google Scholar
• Organisation for Economic Co-operation and Development. Antimicrobial resistance: Tackling the burden in the European union. Paris: OECD; 2019.
   Google Scholar
• Organisation for Economic Co-operation and Development. Stemming the superbug tide: just a few dollars more. Paris: OECD; 2018.
   Google Scholar
• Review on Antimicrobial Resistance. Antimicrobial resistance: tackling a crisis for the health and wealth of nations. Review on Antimicrobial Resistance; 2014.
   Google Scholar
• Klein EY, Van Boeckel TP, Martinez EM, et al. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci USA. 2018;115(15):E3463–e3470. Apr 10
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control. Antimicrobial consumption in the EU/EEA, annual epidemiological report for 2018. Stockholm: European Centre for Disease Prevention and Control; 2019.
   Google Scholar
• European Centre for Disease Prevention and Control. Surveillance of antimicrobial resistance in Europe 2018. Stockholm: ECDC; 2019.
   Google Scholar
• Public Health Agency of Sweden. Swedish work on containment of antibiotic resistance. Stockholm: Public Health Agency of Sweden; 2014.
   Google Scholar
• Swedres-Svarm. Consumption of antibiotics and occurrence of resistance in Sweden. Solna/Uppsala: Swedres-Svarm; 2017.
   Google Scholar
• Australian Commission on Safety and Quality in Health Care. AURA 2021: Third australian report on antimicrobial use and resistance in human health. Sydney: ACSQHC; 2021.
   Google Scholar
• Cars O, Molstad S, Melander A. Variation in antibiotic use in the European union. Lancet. 2001; Jun 9357(9271):1851–1853.
   PubMed Web of Science ®Google Scholar
• Bjerrum L, Boada A, Cots JM, et al. Respiratory tract infections in general practice: considerable differences in prescribing habits between general practitioners in Denmark and Spain. Eur J Clin Pharmacol. 2004;60(1):23–28.
   PubMed Web of Science ®Google Scholar
• OECD. Health at a glance. Paris: OECD Publishing; 2019.
   Google Scholar
• McKenzie D, Rawlins M, Del Mar C. Antimicrobial stewardship: what's it all about? Aust Prescr. 2013;36(4):116–120.
   Google Scholar
• World Health Organization. The Anatomical Therapeutic Chemical Classification System with Defined Daily Doses-ATC/DDD. 2009.
   Google Scholar
• WHO Collaborating Centre for Drug Statistics Methodology. DDD: Definition and general consideration Norway: WHO Collaborating Centre for Drug Statistics Methodology; 2018. [updated 2018-02-17]. Available from: https://www.whocc.no/ddd/definition_and_general_considera/.
   Google Scholar
• WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2020: WHO Collaborating Centre for Drug Statistics Methodology; 2021 [updated 2019-12-16]. Available from: https://www.whocc.no/atc_ddd_index/.
   Google Scholar
• Coast J, Al-Janabi H, Sutton EJ, et al. Using qualitative methods for attribute development for discrete choice experiments: issues and recommendations. Health Econ. 2012;21(6):730–741.
   PubMed Web of Science ®Google Scholar
• Drug Utilisation Sub-Committee of the Pharmaceutical Benefits Advisory Committee. Australian Statistics on Medicines: Australian Government Department of Health. Available from: http://www.pbs.gov.au/info/statistics/asm/australian-statistics-on-medicines.
   Google Scholar
• Australian Government Department of Health. Pharmaceutical Benefits Scheme and Repatriation Pharmaceutical Benefits Scheme Section 85 Supply Data: Australian Government Department of Health; 2020. [updated 2020]. Available from: http://www.pbs.gov.au/info/statistics/dos-and-dop/dos-and-dop.
   Google Scholar
• Australian Bureau of Statistics. Australian Demographic Statistics: Australian Bureau of Statistics; [updated 2020-06-03]. Available from: https://www.abs.gov.au/AUSSTATS/[email protected]/second+level+view?ReadForm&prodno=3101.0&viewtitle=Australian%20Demographic%20Statistics∼Jun%202019∼Latest∼19/12/2019&&tabname=Past%20Future%20Issues&prodno=3101.0&issue=Jun%202019&num=&view=&.
   Google Scholar
• National Board of Health and Welfare. Statistikdatabas för läkemedel [Internet]. Socialstyrelsen; [24 Feb 2020]. Available from: https://sdb.socialstyrelsen.se/if_lak/val.aspx.
   Google Scholar
• De Maeseneer JM, van Driel ML, Green LA, et al. The need for research in primary care. Lancet (London, England). 2003;362(9392):1314–1319.
   PubMed Web of Science ®Google Scholar
• Grimsmo A, Hagman E, Faiko E, et al. Patients, diagnoses and processes in general practice in the nordic countries. An attempt to make data from computerised medical records available for comparable statistics. Scand J Prim Health Care. 2001;19(2):76–82.
   PubMed Web of Science ®Google Scholar
• Britt HM, Henderson J, Bayram C, et al. General practice activity in Australia 2014-15. General practice series. Sydney. 2015.
   Google Scholar
• Gunnarsson R, Ebell MH, Wächtler H, et al. Association between guidelines and medical practitioners' perception of best management for patients attending with an apparently uncomplicated acute sore throat: a cross-sectional survey in five countries. BMJ Open. 2020;10(9):e037884.
   PubMed Web of Science ®Google Scholar
• Wellfare AIoHa. Primary health care in Australia. Canberra: AIHW; 2016.
   Google Scholar
• Mossialos E, Wenzl M, Osborn R, et al. 2017 International profiles of health care systems. New York; Washington: The Commonwealth Fund; 2017.
   Google Scholar
• Martínez-González NA, Keizer E, Plate A, et al. Point-of-Care C-reactive protein testing to reduce antibiotic prescribing for respiratory tract infections in primary care: systematic review and Meta-analysis of randomised controlled trials. Antibiotics. 2020;9(9):610.
   Web of Science ®Google Scholar
• André M, Schwan Å, Odenholt I, The Swedish Study Group On Antibiotic Use*. The use of CRP tests in patients with respiratory tract infections in primary care in Sweden can be questioned. Scandinavian Journal of Infectious Diseases. 2004;36(3):192–197.
   PubMed Web of Science ®Google Scholar
• Melbye H, Stocks N. Point of care testing for C-reactive protein: a new path for Australian GPs? Aust Fam Physician. 2006;35(7):513–517.
   PubMedGoogle Scholar
• Lindström J, Nordeman L, Hagström B. What a difference a CRP makes. A prospective observational study on how point-of-care C-reactive protein testing influences antibiotic prescription for respiratory tract infections in Swedish primary health care. Scand J Prim Health Care. 2015;33(4):275–282.
   PubMed Web of Science ®Google Scholar
• Aabenhus R, Jensen JUS, Jørgensen KJ, Cochrane Acute Respiratory Infections Group, et al. Biomarkers as point-of-care tests to guide prescription of antibiotics in patients with acute respiratory infections in primary care [review]. Cochrane Database of Systematic Reviews. 2014; (11).
   PubMed Web of Science ®Google Scholar
• Molstad S, Lofmark S, Carlin K, et al. Lessons learnt during 20 years of the swedish strategic programme against antibiotic resistance. Bull World Health Organ. 2017;95(11):764–773.
   PubMed Web of Science ®Google Scholar
• Australian Government Department of Health. Australia's first national antimicrobial resistance strategy 2015-2019. Canberra: Australian Government; 2015.
   Google Scholar
• Australian Commission on Safety and Quality in Health Care (ACSQHC). AURA 2019: Third Australian report on antimicrobial use and resistance in human health. Sydney: ACSQHC; 2019.
   Google Scholar
• Touboul-Lundgren P, Jensen S, Drai J, et al. Identification of cultural determinants of antibiotic use cited in primary care in Europe: a mixed research synthesis study of integrated design “culture is all around us. BMC Public Health. 2015;15(1):1–9.
   PubMed Web of Science ®Google Scholar
• Deschepper R, Grigoryan L, Lundborg CS, et al. Are cultural dimensions relevant for explaining cross-national differences in antibiotic use in Europe? BMC Health Serv Res. 2008;8(1):123–129.
   PubMed Web of Science ®Google Scholar
• Dallas A, van Driel M, Morgan S, et al. Antibiotic prescribing for acute otitis media and acute sinusitis: a cross-sectional analysis of the ReCEnT study exploring the habits of early career doctors in family practice. Fam Pract. 2017;34(2):180–187.
   PubMed Web of Science ®Google Scholar
• McCullough AR, Pollack AJ, Plejdrup Hansen M, et al. Antibiotics for acute respiratory infections in general practice: comparison of prescribing rates with guideline recommendations. Med J Aust. 2017;207(2):65–69.
   PubMed Web of Science ®Google Scholar
• O’Keefe C, Thompson A, McKenzie D, et al. Concordance with antibiotic guidelines in australian primary care: a retrospective study of prior-to-hospital therapy. Int J Clin Pract. 2019;73(12):e13427.
   Web of Science ®Google Scholar
• Australian Commission on Safety and Quality in Health Care. Antimicrobial stewardship in australian health care 2018. Sydney: ACSQHC; 2018.
   Google Scholar
• Tyrstrup M, Beckman A, Molstad S, et al. Reduction in antibiotic prescribing for respiratory tract infections in swedish primary care- a retrospective study of electronic patient records. BMC Infect Dis. 2016;16(1):709
   PubMed Web of Science ®Google Scholar
• Kornfalt Isberg H, Hedin K, Melander E, et al. Increased adherence to treatment guidelines in patients with urinary tract infection in primary care: a retrospective study. PLoS One. 2019;14(3):e0214572.
   PubMed Web of Science ®Google Scholar